The results of the analyses support that the safety profile of ferumoxytol is comparable between first and second administration of the number of regardless days in between the administrations.. AMAG Pharmaceuticals’ abstract on ferumoxytol for CKD accepted for demonstration at NKF 2010 AMAG Pharmaceuticals, Inc. today announced that one abstract has been approved for demonstration at the National Kidney Foundation 2010 Spring Clinical Meeting being held April 13-17, 2010 in Orlando, FL.Carl Naraynassamy – who’s well respected for his contributions to the fields of clinical study and pharmaceutical medicine education globally. I am self-confident that with his eyesight, business acumen and clinical research expertise, Accovion’s operations in the UK will continue to prosper. In 2011, Accovion’s strategic strategy includes formalizing activities in several other European countries by establishing additional subsidiaries. With its active, well-planned growth, Accovion aims to offer its clients a broader spectrum of country-specific clinical research experience, all under one roofing and all providing the quality providers that Accovion is known for.
Agito Networks wins best honors in the annual MobileVillage Cell Star Awards program Agito Systems, Inc.